Coagulation Factor IXa-Factor VIIIa complex (Intrinsic tenase complex)

The Coagulation Factor IXa-Factor VIIIa complex, frequently referred to as the intrinsic tenase complex, is a pivotal enzymatic assembly within the blood coagulation cascade [1]. It is composed of the serine protease Factor IXa and its essential non-enzymatic cofactor, Factor VIIIa, which together localize on the surface of activated platelets or phospholipids in the presence of calcium ions [2,3]. The primary biological role of this complex is the rapid and efficient activation of Factor X to Factor Xa, a critical step that precedes the thrombin burst necessary for stable fibrin clot formation [1]. Deficiencies in either Factor VIII or Factor IX lead to the hereditary bleeding disorders Hemophilia A and Hemophilia B, respectively, highlighting the complex's central role in hemostasis [3]. Conversely, the complex is a target for antithrombotic therapy, as its inhibition can prevent pathological clot formation [7]. Modern therapeutic advancements have introduced bispecific antibodies, such as emicizumab, which mimic the bridging function of Factor VIIIa to restore the activity of the complex in patients with Hemophilia A [4]. Monitoring the efficacy of such treatments often involves specialized assays like thrombin generation or Factor Xa activity tests, as traditional coagulation assays may be misleading [4,5].

Other names

Intrinsic tenase complexFIXa-FVIIIa complexFactor IXa-Factor VIIIa complexFactor X activating complexTenase complex

Bispecific antibody bridging of Factor IXa and Factor X to mimic Factor VIIIa cofactor function; Proteolytic activation of Factor X by Factor IXa within the complex.